Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
17.865
Zitationen
35
Autoren
2016
Jahr
Abstract
Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that did not use randomisation to allocate units (individuals or clusters of individuals) to comparison groups. The tool will be particularly useful to those undertaking systematic reviews that include non-randomised studies.
Ähnliche Arbeiten
Meta-analysis in clinical trials
1986 · 38.745 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 37.543 Zit.
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
2018 · 37.131 Zit.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.471 Zit.
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · 28.346 Zit.
Autoren
- Jonathan A C Sterne
- Miguel A. Hernán
- Barnaby C Reeves
- Jelena Savović
- Nancy D Berkman
- Meera Viswanathan
- David Henry
- Douglas G. Altman
- Mohammed Ansari
- Isabelle Boutron
- James R. Carpenter
- An‐Wen Chan
- Rachel Churchill
- Jonathan J Deeks
- Asbjørn Hróbjartsson
- Jamie J Kirkham
- Peter Jüni
- Yoon K. Loke
- Theresa D Pigott
- Craig Ramsay
- Deborah L. Regidor
- Hannah R. Rothstein
- Lakhbir Sandhu
- Pasqualina Santaguida
- Holger J. Schünemann
- Beverly Shea
- Ian Shrier
- Peter Tugwell
- Lucy Turner
- Jeffrey C. Valentine
- Hugh Waddington
- Elizabeth Waters
- George A. Wells
- Penny Whiting
- Julian P. T. Higgins
Institutionen
- University of Bristol(GB)
- Harvard–MIT Division of Health Sciences and Technology(US)
- Harvard University(US)
- Massachusetts Institute of Technology(US)
- University Hospitals Bristol NHS Foundation Trust(GB)
- National Institute for Health Research(GB)
- RTI International(US)
- Public Health Ontario(CA)
- University of Toronto(CA)
- Nuffield Orthopaedic Centre(GB)
- University of Oxford(GB)
- University of Ottawa(CA)
- Sorbonne Paris Cité(FR)
- Inserm(FR)
- Université Paris Cité(FR)
- London School of Hygiene & Tropical Medicine(GB)
- MRC Clinical Trials Unit at UCL(GB)
- University College London(GB)
- Women's College Hospital(CA)
- University of York(GB)
- University of Birmingham(GB)
- University of Southern Denmark(DK)
- Odense University Hospital(DK)
- University of Liverpool(GB)
- St. Michael's Hospital(CA)
- University of East Anglia(GB)
- Loyola University Chicago(US)
- University of Aberdeen(GB)
- Kaiser Permanente(US)
- Baruch College(US)
- McMaster University(CA)
- Cochrane(CA)
- Ottawa Hospital(CA)
- McGill University(CA)
- Jewish General Hospital(CA)
- Ottawa Hospital Research Institute
- University of Louisville(US)
- London International Development Centre(GB)
- University of Melbourne(AU)